Gene Query: CYB5R3

Dataset Description Geneva Score
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 66.38
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 58.9
mRNA expression in iPS cells generated by a synthetic self-replicative RNA 49.77
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 48.04
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 40.02
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 40.02
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 36.47
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 36.44
Impact of dieldrin on transcription in Jurkat T cells 33.2
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 29.11
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 27.64
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 27.64
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 27.62
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 27.62
Gene expression changes after depletion of Cyclin F and atypical E2Fs in HeLa cells. 26.75
The interplay between SOX4 and SMAD3 in the context of breast cancer 26.45
Transcriptome-wide analysis of adipose circular RNAs reveals their dynamic regulation in obesity and functional role in adipogenesis 25.88
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 25.59
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 25.31
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 24.59
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 23.79
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 23.4
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 23.17
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 23.07
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_human] 22.67
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 20.6
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma [longRNA] 20.23
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 20.06
An integrative analysis of non-coding regulatory DNA variations associated with autism 20.0
hnRNP C is a key regulator of protein synthesis in mitosis 19.96
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 19.34
Hypoxic regulation of transcription in HUVEC is mediated by EPAS1 18.83
Expansion, in vivo-ex vivo cycling and genetic manipulation of primary human hepatocytes 18.61
UPA-Seq: Prediction of functional lncRNAs using the sensitivities to UV-crosslinking 18.38
PAK4 suppresses RELB to prevent senescence-like growth arrest in breast cancer 18.29
Transcriptome-wide study of the response of human trabecular meshwork cells to the substrate stiffness increase 17.73
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq and microarray 17.68
Gene expression analysis of airway epithelial cells exposed to flagellin via RNA-seq 17.68
Modeling Familial Cancer with iPSC Approaches 17.65
Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing 17.56
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation (Human_RWPE1_RNA-Seq) 17.46
Identification of an NKX3.1-G9a-UTY regulatory network that controls prostate differentiation 17.46
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 17.14
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 16.89
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 16.8
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 16.65
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy 16.55
Genomic Reorganization of Lamin-Associated Domains in Cardiac Myocytes is Associated with Differential Gene Expression and DNA Methylation in Human Dilated Cardiomyopathy [RNA-Seq] 16.55
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 15.69
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 15.68
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 15.68
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 15.59
scRNASeq analysis of cycling cardiomyocytes 15.52
Appropriately Differentiated ARPE-19 Cells Regain a Native Phenotype and Similar Gene Expression Profile 15.35
Effects of Freeze-Thawing and Intravenous Infusion on Mesenchymal Stromal Cell Gene Expression 15.23
Dual role of CSL (RBP-Jk) and NOTCH1 in CAF 14.85
Dual role of CSL (RBP-Jk) and NOTCH1 in cancer-associated fibroblast genome stability and expansion [RNA-seq] 14.85
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 14.81
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 14.79
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 14.56
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 14.56
Stem and effector CD8 T-cells from human cancers 14.47
mRNA expression data from human parthenogenetic haploid ESCs (hPGES), normal ESCs (H9) and human fibroblast 14.45
Genomic analysis of human parthenogenetic haploid ESCs (hPGES), normal human ESCs(H9) and human forskin fibroblast 14.45
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 14.01
Expression and functions of long noncoding RNAs during human T helper cell differentiation 13.93
Nudt3 is a mRNA Decapping Enzyme That Modulates Cell Migration 13.89
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.79
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 13.79
Patient iPSC-derived neural stem cells display progressive enlargement of lysosomes and disruptions of glycosaminoglycan pathway and autophagy in concordance with clinical severity of Mucopolysaccharidosis I 13.67
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 13.58
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines [HTS] 13.56
Functional characterization of RNA-binding protein IMP2 in primary Glioma cell lines 13.56
Profiling of gene expression using RNA-Seq in fibroblasts, iPSCs, iPSC-derived neurons and cells overexpressing Onecut transcription factors 13.54
Changes in chromatin accessibility and gene expression induced by overexpression of ONECUT transcription factors 13.54
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 13.51
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia [RNA-seq] 13.31
CBFb-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia 13.31
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 13.26
HEXIM1 is induced by DHODH inhibition to suppress melanoma 13.24
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 13.24
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 13.23
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 13.23
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response 13.16
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 13.08
RNA m5C Methylation in breast cancer using MeRIP-Seq 13.03
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 12.95
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 12.95
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 12.93
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 12.93
Radiomic and gEnomic approaches for the enhanced DIagnosis of REnal Cancer (REDIRECt): A translational pilot study 12.83
High-throughput sequencing of pluripotent cells 12.77
Suppression of NAF-1 in Breast Cancer Cells Reduces their Tumorigenicity by Interfering with Cellular Iron Distribution and Metabolism and Ensuing ROS Formation and Apoptosis 12.6
Transcriptome sequencing of K-562 cells 12.57
Ascorbate Suppresses VEGF Expression in Retinal Pigment Epithelial Cells 12.52
Transcriptomic Profiling of Posterior Polymorphous Corneal Dystrophy 12.39
Multiple mechanisms disrupt let-7 miRNA biogenesis and function in neuroblastoma 12.39
Differentiation enhances Zika virus infection in neuronal brain cells 12.38
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 12.37
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 12.25
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 12.23
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 12.08
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 12.07
Transcriptome analysis of Jurkat T-ALL clones from control and CBAP-knockdown/knockout sets 11.98
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 11.95
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 11.89
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations [RNA-seq] 11.86
Three-dimensional disorganisation of the cancer genome occurs coincident with long range genetic and epigenetic alterations 11.86
Replicated transcriptome profiling of Normal and Cancerous Prostate Cells [RNA-Seq] 11.76
SHQ1 regulation of RNA splicing is required for T-lymphoblastic leukemia cell survival 11.7
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 11.53
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia [RNA-seq] 11.47
Lymphocyte-specific chromatin accessibility pre-determines glucocorticoid resistance in acute lymphoblastic leukemia 11.47
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 11.44
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 11.4
Transcriptome analysis of human embryonic stem cells (hESCs) and human fibroblasts upon rapamycin 11.38
In vitro differentiation of human embryonic stem cells into ovarian follicle-like cells 11.21
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 11.16
RNA-seq of cells with TET1 knockout 11.16
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 11.12
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.08
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 11.08
Transcriptional alteration after ionizing radiation exposure in human fibroblasts, iPSCs and NPCs 11.06
Transcriptomic analysis of IPF lung-associated and normal peripheral blood T cells 10.99
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 10.94
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 10.81
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines [RNA-Seq] 10.74
Discovery of naturally occurring ESR1 mutations during acquisition of resistance to endocrine therapy in widely used estrogen receptor positive breast cancer cell lines 10.74
ETV7 and interferon response 10.73
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 10.73
RNA sequencing of lncRNAs knockdown in human pancreatic cancer cell lines 10.65
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 10.64
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival 10.64
AKT Inhibition Promotes Non-autonomous Cancer Cell Survival [RNA-Seq] 10.64
ARID1A and ARID1B loss in HCT116 and TOV21G cells 10.6
Transcriptomic profiling discloses molecular and cellular events related to neuronal differentiation in SH-SY5Y cells 10.6
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 10.58
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming 10.53
Bromodomain inhibition of the co-activators CBP/EP300 facilitates reprogramming (RNA-seq fibroblasts) 10.53
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 10.52
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 10.42
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 10.36
TGF-β regulation of miRNA expression in pancreatic cancer 10.34
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 10.26
RNA-sequencing of milk cells extracted from pre-partum secretions and longitudinally from mature human milk across the first year of lactation 10.22
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 10.02
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 10.02
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 10.02
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 10.0
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 9.98
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia 9.97
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 9.86
Complementary Post Transcriptional Regulatory Information is Detected by PUNCH-P and Ribosome Profiling 9.83
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 9.81
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 9.79
Transcriptome profile of ATP7B KO cells and WT cells treated with Copper (Cu) to study Autophagy as a pro-survival mechanism in Wilson disease 9.79
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 9.79
MUC1-C represses the RASSF1A tumor suppressor and activated Kras signaling in human carcinoma cells 9.78
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 9.67
Sensing self and nonself circular RNAs 9.65
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 9.64
Patient-derived luminal breast cancer xenografts with progestins 9.64
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 9.64
Hepatocyte maturation 9.49
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 9.47
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 9.43
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 9.33
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 9.33
The age and genomic integrity of neurons after cortical stroke in humans 9.27
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 9.24
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 9.24
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 9.16
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 9.16
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 9.15
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 9.12
Tracking distinct RNA populations using efficient and reversible covalent chemistry 9.07
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 9.07
CD86 regulates a pro-survival signal in myeloma cells 9.06
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 9.05
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 9.01
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 9.0
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 8.89
A practical evaluation of alignment algorithms for RNA variant calling analysis 8.87
The effect of engineered del(7q) on induced pluripotent stem cells (iPSCs) derived from patients with Shwachman Diamond Syndrome (SDS). 8.84
RNA-Seq comparisons of gene expression profiles of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 8.81
ChIP-seq and RNA-Seq analyses of epithelial and mesenchymal cells - HMLE, N8, N8-CTx 8.81
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 8.79
EP400 is required for Max and MCPyV mediated gene activation 8.79
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 8.71
CD13 and ROR2 permit isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 8.69
Isolation of highly enriched cardiac mesoderm from differentiating human embryonic stem cells 8.69
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 8.68
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 8.67
Genome wide expression change in LCC2 and MCF-7 cells 8.64
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 8.63
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 8.53
Altering cancer transcriptomes using epigenomic inhibitors 8.53
JAK2 is dispensable for maintenance of JAK2 mutant B-cell acute lymphoblastic leukemias 8.52
Comparative gene expression profiling of MHH-CALL4 cells subject to pharmacological JAK2 inhibitor treatment (ruxolitinib or CHZ868) or shRNA-mediated JAK2 depletion in vitro 8.52
Transcriptional landscape of epithelial and immune cell populations revealed through FACS-seq of healthy human skin 8.51
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT, U0126, CYHX, ActD, EGF, FGF, or IGF and labelled with 4SU 8.51
Time-course expression data from HEK293∆RAF1:ER cells stimulated with 4OHT and labelled with 4SU 8.51
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 8.51
Microprocessor mediates transcription termination in long noncoding microRNA genes 8.45
High-Throughput Kinetic Analysis of Fractional Killing 8.45
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 8.45
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 8.45
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 8.41
Transcriptome profiling of Normal and Cancerous Prostate Cells 8.33
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 8.28
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 8.22
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction 8.2
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 8.2
8.17
The X-linked DDX3X RNA helicase dictates translation re-programming and metastasis in melanoma 8.16
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 8.13
mRNA sequencing of the mouse and human Hep-Orgs, Chol-Orgs and primary hepatocytes 8.11
Tracing Enhancer Networks using Epigenetic Traits (TENET) 8.09
Overexpression and knockdown experiment for circCSNK1G3 8.09
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 8.03
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 8.03
Defective transcription elongation in a subset of cancers confers immunotherapy resistance 7.96
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 7.89
Genome-wide expression profiling of an in vitro model for studying esophageal epithelial differentiation 7.85
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 7.83
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 7.81
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 7.81
Gene expression profiling of leukemia cells following asparagine depletion 7.77
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 7.64
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 7.63
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 7.61
Analyses of a panel of transcripts and construction of RNA networks in hepatocellular carcinoma 7.61
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 7.6
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 7.57
Stably-paused genes revealed through inhibition of transcription initiation by the TFIIH inhibitor Triptolide 7.48
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 7.45
SLIGRL-induced gene expression changes in NHEK cells 7.37
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 7.31
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.29
3’READS+, a sensitive and accurate method for 3’ end sequencing of polyadenylated RNA 7.23
Transcriptome-wide response to synthetic chromatin protein PcTF 7.22
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 7.22
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 7.17
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 7.14
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 7.13
Cajal bodies are linked to genome conformation 7.12
Cajal bodies are linked to genome conformation [RNA-Seq] 7.12
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 7.1
Exploring the RNA landscape of endothelial exosomes 7.06
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 7.01
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 6.96
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 6.96
The role of CFTR in islet function 6.9
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 6.86
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 6.85
Human Pancreatic Islets Expressing HNF1A Variant Have Defective β cell Transcriptional Regulatory Networks 6.82
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 6.82
DDX54 regulates transcriptome dynamics during DNA damage response [4SU-seq] 6.73
CD74 role in transcription regulation 6.72
CD74 role in transcription regulation [RNA-seq] 6.72
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 6.72
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 6.71
Role of XRN2 ribonucleolytic activity in RNA metabolism 6.71
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 6.7
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 6.7
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 6.68
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 6.66
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 6.66
Mechanistic Model-Guided Study of Embryonic Morphogenesis 6.62
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 6.59
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 6.58
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 6.56
In vitro differentiation of human low threshold mechanoreceptive (LTMR) neurons from embryonic stem cells 6.56
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 6.52
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 6.45
Rate of elongation by RNA polymerase II is influenced by specific gene features and histone modifications 6.34
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer [RNA-seq] 6.32
FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer 6.32
METTL3 and WTAP 6.3
Transcriptional profiling identifies differential expression of long non-coding RNAs in Jo-1 associated and inclusion body myositis 6.29
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 6.25
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.18
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.18
Exogenous pyruvate represses histone gene expression to inhibit cancer cell proliferation via the NAMPT-NAD + -SIRT1 pathway 6.09
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 6.07
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 5.99
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 5.97
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 5.91
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 5.9
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 5.9
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 5.89
Large-scale profiling of intracellular signalling pathway activation reveals major distinctions between airway smooth muscle cells of asthmatics and non-asthmatics. 5.82
Identification of Atrial Fibrillation associated genes and functional non-coding variants 5.79
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 5.78
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 5.76
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 5.75
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 5.74
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 5.74
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.7
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 5.68
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 5.68
RNA-seq and flow-cytometry of conventional, scalp, and palmoplantar psoriasis reveal shared and distinct molecular pathways 5.63
The transcriptome and chromatin accessbility landscape of mammalian germline 5.63
Allelic expression mapping across cell lineages reveal repressor disruption among disease SNPs 5.56
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 5.55
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 5.55
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 5.44
Comparative Analysis of Cas9 Activators Across Multiple Species 5.4
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 5.38
Triple vectors expand AAV transfer capacity in the retina 5.38
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 5.26
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 5.23
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 5.21
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 5.2
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 5.19
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 5.16
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 5.08
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 5.04
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 5.03
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 5.03
cKIT+ sorted cells from 57-137 day old fetal testes and ovaries 5.03
RNA-Seq of cKIT+ sorted cells from 53-137 day old fetal testes and ovaries and RNA-Seq of TRA-1-81+ H1 and UCLA1 hESCs. 5.03
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 4.99
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 4.99
Iron response of HepG2 cells 4.95
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 4.9
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 4.89
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 4.88
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 4.79
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 4.78
Positively selected enhancer elements endow tumor cells with metastatic competence 4.78
Hepatitis C virus functionally sequesters miR-122 4.77
Hepatitis C virus functionally sequesters miR-122 [RNA-Seq] 4.77
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.72
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 4.66
Transcriptional regulation in pluripotent stem cells by Methyl CpG binding protein 2 (MeCP2) 4.65
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 4.62
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.52
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 4.46
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 4.4
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 4.37
circRNA-sequencing 4.32
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 4.2
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 4.18
The bromodomain protein BRD4 regulates splicing during heat shock 4.12
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 4.11
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 4.06
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 4.03
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 4.03
Molecular Pathology of adverse local tissue reaction caused by metal-on-metal implants 3.96
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 3.93
Transcriptional profiling of PBMC from patients with aGvHD and patients without aGvHD after alloHSCT 3.91
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 3.9
mRNA recovered upon RNF219 IP. [RNA-IP] 3.84
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 3.84
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 3.83
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 3.8
Gene expression in skeletal muscle in older individuals subject to ten days of complete bed rest. 3.79
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 3.79
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 3.79
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 3.78
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 3.78
Metastasis in triple-negative breast cancer 3.77
Functional and genomic characterization of a xenograft model system for the study of metastasis in triple-negative breast cancer. 3.77
Effect of BB608 on Gene Expression in HNSCC Cell Line 3.76
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 3.74
RNA-sequencing of human mammary epithelial cells (HMLEs) transduced in vitro with a shRNA against SOX4 or a scrambled shRNA in untreated and TGF-β-treated (16 hours) conditions 3.61
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.58
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 3.52
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 3.49
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 3.48
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 3.44
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 3.44
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 3.42
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 3.41
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 3.35
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 3.33
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.23
Interaction between mitoNEET and NAF-1 in cancer cells 3.23
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.18
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 3.13
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 3.09
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 3.09
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 3.07
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 2.94
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 2.86
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.82
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.82
RNA seq_PDX2_SHP099 2.55
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 2.53
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia 2.5
Chromatin mapping and single-cell immune profiling defines the temporal dynamics of ibrutinib drug response in chronic lymphocytic leukemia [scRNA-seq] 2.5
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 2.49
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 2.45
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 2.45
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 2.44
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 2.4
Regulatory network controlling tumor-promoting inflammation in human cancers 2.4
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 2.3
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 2.29
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 2.21
Changes in human endometrial gland transcriptome over the window of implantation 2.18
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 2.14
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.14
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.13
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 2.12
Single-cell Transcriptomic Atlas of the Human Retina Identifies Cell Types Associated with Age-Related Macular Degeneration [Microfluidics] 2.11
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 2.09
Whole transcriptome sequencing of the human thyroid primary cells with knock-down of the NRG1 gene 2.08
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 2.06
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 2.05
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 1.96
Capturing the Interactome of Newly Transcribed RNA (RICK) 1.96
Capturing the Interactome of Newly Transcribed RNA 1.96
Anti-Inflammatory Effects of Budesonide in Human Fetal Lung 1.91
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells 1.91
Glioma-derived miRNA-containing extracellular vesicles induce angiogenesis by reprogramming brain endothelial cells (longRNA-seq) 1.91
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 1.91
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 1.9
HEK293 TFAM Knockout Expression Study 1.88
RNA-Seq data for five HER2 over-expressed samples with twelve green fluorescent protein control samples using human mammary epithelial cells 1.77
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 1.77
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 1.75
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 1.66
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.65
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.6
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.6
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 1.6
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.56
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.56
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 1.54
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.53
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 1.5
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.47
Molecular mechanism underlying increased ischemic damage in the ALDH2*2 genetic polymorphism using a human iPSC model system 1.47
Comparison of 7 small cell lung cancer PDX models, cultured ex vivo, for response to LSD1 inhibitor RG6016/ORY1001 1.43
DAOY-Notch1/Notch2 knockout: transcriptome comparison 1.43
Identifying deer antler proliferation and mineralization genes using comparative RNA-seq 1.41
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.36
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 1.35
Aortic Valve Tissue: Stenosis vs. Sclerosis 1.32
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 1.28
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 1.28
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 1.28
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 1.26
Identification of a LIF-responsive replication-competent human β cell 1.26
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 1.15
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 1.14
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 1.14
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.14
Transcriptome sequencing identify a recurrent CRYL1-IFT88 chimeric transcript in hepatocellular carcinoma 1.14
Profiling of escape kinetics of viruses subjected to RNAi 1.14
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 1.11
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.1
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 1.08
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 1.05
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 1.05
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 1.05
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 1.04
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 1.04
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.01
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 1.01
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 0.96
Gene expression analysis of human adenomas. 0.9
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 0.9
A stably self-renewing adult blood-derived induced neural stem cell exhibiting patternability and epigenetic rejuvenation 0.88
Engineered Nanointerfaces for Microfluidic Isolation and Molecular Profiling of Tumor-specific Extracellular Vesicles 0.79
Pro-angiogenic Ginsenoside F1 and Rh1 Inhibit Vascular Leakage by Modulating NR4A1 0.79
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.76
Enhancer activation during EGF response 0.71
Muscle transcriptome analysis following Total Knee Arthroplasty with Tourniquet 0.7
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 0.65
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 0.64
Transcriptome analysis of fetal Klinefelter testis tissue samples compared to controls 0.6
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.58
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 0.58
Illumina Total RNA-seq in HeLa 0.58
Dilated cardiomyopathy vs Myocarditis 0.52
Induction of Cardiomyocyte Proliferation [pz-822_human] 0.49
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 0.49
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.45
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.42
Chemical Enhancement of Direct Cardiac Reprogramming In Vitro and In Vivo 0.41
High-throughput single cell transcriptome analysis and CRISPR screen identify key β cell-specific disease genes 0.35
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.33
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 0.32
MHC Transcriptomic landscape at haplotype-specific resolution 0.29
transcriptome studies of BRD4 inhibitor BDF-1253 on renal clear carcinoma 786-O cells 0.2
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.17
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.17
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.15
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.15
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.13
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.1
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.08
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.08
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.06
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 0.05
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.05
Human pulmonary artery endothelial cells (hPAECs) with downregulated BMPR2 signaling demonstrate a unique gene expression signature after exposure to overexpression of AdAlox5 0.03


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation